Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Predictors of Prognosis in Patients With Critical Illness.

13 juillet 2021 mis à jour par: Taoyuan General Hospital

Recently, intensive care unit acquired weakness (ICUAW) has become a hotspot issue in the patients with critical illness. The symptoms of ICUAW, including sensory impairment and muscle atrophy, may lead to poor quality of life even though the patients discharged from the ICU for a long time. Therefore, an ounce of prevention is worth a pound of cure. At the same time, early evaluation is necessary to keep critically ill patients away from ICUAW. Medical Research Council (MRC) scale is the most common approach for diagnosis clinically. Regarding the interrater variation of MRC, handgrip strength (HGS) has been thought to be a simple and accurate alternative. However, HGS does not belong to antigravity or respiratory muscle which are the first to be affected by immobilization. It is still unknown whether HGS can represent the general muscle condition in ICU or not.

Additionally, previous studies have proved that patients with critical illness in the ICU would have better prognosis and less complications, if they undergo physical therapy as soon as possible. In addition to early ventilator weaning and reduced mortality rate, physical therapy could enhance quality of life (QoL) after patient discharges from hospital. However, early mobility in the ICU mainly emphasizes cardiopulmonary patients due to the traditional concept in Taiwan. Hence, the duration of mechanical ventilation in the critical patients will affect the timing to receive physical therapy, even impact the improvement of QoL.

Because of these reasons, this study will investigate the relationship between HGS and muscle mass among patients with critical illness and find the predictors of the short-term and long-term goals in the ICU, including ventilator weaning and QoL after hospital discharge.

Aperçu de l'étude

Description détaillée

This prospective and observational study will be divided into 2 parts: 1) The association between handgrip strength and muscle mass in intensive care unit patients. 2) Predictors of short-term and long-term goals in ICU.

Patients in the surgery intensive care unit of Taoyuan General Hospital will be recruited and evaluated in 48 hours from admission to ICU. The outcome measures include HGS assessed by electronic hand dynamometer and muscle thickness of diaphragm and quadriceps detected by ultrasound.

The short-term goal is weaning ventilator, and the long-term goal is quality of life after discharge from hospital assessed through SF-36 Taiwan version. Patients in the surgery intensive care unit of Taoyuan General Hospital will be recruited and evaluated in 48 hours after ICU admission. The collected data contain muscle strength, muscle mass, physical function, respiratory function, and observation of delirium or not. The evaluations of muscle strength include 3 parts which are limbs(handgrip), respiratory muscle(Maximal Inspiratory Pressure), and general muscle strength(Medical Research Council scale); Secondly, the evaluations of muscle mass divide 2 parts which are limbs(muscle thickness of quadriceps) and respiratory muscle(muscle thickness of diaphragm); Thirdly, the evaluations of physical function are 2 ways which are FSS-ICU and 2 mins walk test after discharge from the ICU; Fourthly, the evaluations of respiratory function contain 3 measurements of FEV1, FVC, and FEV1/FVC; Finally, the evaluation of delirium is assessed by CAM-ICU.

The statistical analysis will use SPSS version 24. Pearson correlation test will be conducted to investigate the association between HGS and muscle thickness. Multiple regression will be used to investigate the predictors for weaning ventilator successfully and quality of life after hospital discharge.

Type d'étude

Observationnel

Inscription (Réel)

400

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

      • Taoyuan, Taïwan, 330
        • Department of Rehabilitation, Taoyuan General Hospital, Ministry of Health and Welfare, Taiwan

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Enfant
  • Adulte
  • Adulte plus âgé

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

Méthode d'échantillonnage

Échantillon non probabiliste

Population étudiée

Patients in the surgery intensive care unit will be recruited and evaluated in 48 hours from admission to ICU

La description

Inclusion Criteria:

  • Patients in the surgery intensive care unit will be recruited and evaluated in 48 hours from admission to ICU

Exclusion Criteria:

  • Hemodynamic instability patients, e.g., patients with ECMO
  • Patients refuse to participate this study

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Part 1: Change of handgrip strength (HGS) from ICU admission to ICU discharge
Délai: every day during the ICU stay until patients discharge from ICU assessed up to 14 days
Handgrip strength (HGS) assessed by electronic hand dynamometer(Electronic hand dynamometer, CAMRY, MODEL, EH101)
every day during the ICU stay until patients discharge from ICU assessed up to 14 days
Part 1: Change of diaphragm thickness from ICU admission to ICU discharge
Délai: every day during the ICU stay until patients discharge from ICU assessed up to 14 days
Muscle thickness of diaphragm and quadriceps detected by ultrasound(GE vivid S5)
every day during the ICU stay until patients discharge from ICU assessed up to 14 days
Part 2: Change of Handgrip strength (HGS)
Délai: Baseline: admission to ICU in 48 hours. Progress: the day that patients received weaning profile test
Change of Handgrip strength (HGS) assessed by electronic hand dynamometer(Electronic hand dynamometer, CAMRY, MODEL, EH101)
Baseline: admission to ICU in 48 hours. Progress: the day that patients received weaning profile test
Part 2: Change of General muscle strength
Délai: Baseline: admission to ICU in 48 hours. Progress: the day that patients received weaning profile test
Change of General muscle strength- MRC scale
Baseline: admission to ICU in 48 hours. Progress: the day that patients received weaning profile test
Part 2: Change of Muscle mass
Délai: Baseline: admission to ICU in 48 hours. Progress: the day that patients received weaning profile test
Muscle thickness of diaphragm and quadriceps detected by ultrasound (GE vivid S5)
Baseline: admission to ICU in 48 hours. Progress: the day that patients received weaning profile test
Part 2: Respiratory muscle strength
Délai: the day that patient received weaning profile tests during ICU
Respiratory muscle strength- Maximal Inspiratory Pressure(MIP)
the day that patient received weaning profile tests during ICU
Part 2: Change of Physical function
Délai: Baseline: admission to ICU in 48 hours. Progress: the day that patients received weaning profile test
Change of FSS-ICU
Baseline: admission to ICU in 48 hours. Progress: the day that patients received weaning profile test
Part 2: Physical function at ICU discharge
Délai: conducted at the day of ICU discharge
2 mins walk test
conducted at the day of ICU discharge
Part 2: Change of Delirium
Délai: conducted every day in the ICU
CAM-ICU
conducted every day in the ICU
Part 2: Respiratory function
Délai: conducted at the day of ICU discharge
FVC, FEV1, FEV1/ FVC assessed by ezOxygen (EZO-G001)
conducted at the day of ICU discharge
Part 2: Quality of life- SF-36(Taiwan version)
Délai: conducted by phone call at discharge for 6 months from ICU
SF-36(Taiwan version)
conducted by phone call at discharge for 6 months from ICU

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chaise d'étude: Huan-Jui Yeh, Department of Rehabilitation, Taoyuan General Hospital, Ministry of Health and Welfare

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Publications générales

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 janvier 2020

Achèvement primaire (Réel)

13 juillet 2021

Achèvement de l'étude (Réel)

13 juillet 2021

Dates d'inscription aux études

Première soumission

25 mai 2021

Première soumission répondant aux critères de contrôle qualité

30 mai 2021

Première publication (Réel)

4 juin 2021

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

19 juillet 2021

Dernière mise à jour soumise répondant aux critères de contrôle qualité

13 juillet 2021

Dernière vérification

1 juillet 2021

Plus d'information

Termes liés à cette étude

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner